logo

For the Inventor, By the Inventor

Daejeon, South Korea

Jong-Min Han

This inventor holds 5 USPTO granted patents. Top assignee: Korea Research Institute of Bioscience and Biotechnology. Active years: 2010-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jong-Min Han. Retrieved from https://idiyas.com/inventor/jong-min-han

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5

% Patents Active = 20.0

Average Co-Inventor Count = 6.9

ph-index = 1


Company Filing History:

goldMedal5 out of 334 
 
Korea Research Institute of Bioscience and Biotechnology
 patents

Years Active: 2010-2016

Loading Chart...
5 patents (USPTO):Explore Patents
1. 9381222 - Compositions for preventing and treating obesity, hyperlipidemia, atherosclerosis, fatty liver, diabetes or metabolic syndrome containing extracts of glycine max leaves or fractions isolated from the same as an active ingredient (2016-07-05),
2. 8399662 - [object Object] (2013-03-19),
3. 8362034 - Quinoline compound, and composition containing centipede extract or compounds isolated therefrom for prevention and treatment of cardiovascular disease (2013-01-29),
4. 8212042 - Quinoline compound, and composition containing centipede extract or compounds isolated therefrom for prevention and treatment of cardiovascular disease (2012-07-03),
5. 7642291 - [object Object] (2010-01-05),

Title: Innovations and Contributions of Jong-Min Han

Introduction

Jong-Min Han is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the fields of biotechnology and pharmaceuticals. With a total of 5 patents, his work focuses on developing innovative solutions for various health issues.

Latest Patents

Among his latest patents, one notable invention is related to compositions for preventing and treating obesity, hyperlipidemia, atherosclerosis, fatty liver, diabetes, or metabolic syndrome. This invention utilizes extracts of glycine max leaves or fractions isolated from the same as an active ingredient. Another significant patent involves novel O-acyloxime derivatives, which are aimed at preventing and treating cardiovascular diseases. These derivatives have shown excellent inhibitory effects on Lp-PLA, making them valuable in addressing conditions such as hyperlipidemia and myocardial infarction.

Career Highlights

Jong-Min Han is affiliated with the Korea Research Institute of Bioscience and Biotechnology. His work at this esteemed institution has allowed him to focus on groundbreaking research and development in the field of health and medicine. His innovative approaches have garnered attention and recognition within the scientific community.

Collaborations

Throughout his career, Jong-Min Han has collaborated with notable colleagues, including Tae-Sook Jeong and Woo-Song Lee. These collaborations have further enhanced the impact of his research and inventions.

Conclusion

Jong-Min Han's contributions to biotechnology and pharmaceuticals demonstrate his commitment to addressing critical health challenges. His innovative patents reflect a dedication to improving health outcomes through scientific research and development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…